Valuation: Labcorp Holdings Inc.

Market Cap 24.34B 21.37B 19.88B 18.24B 34.27B 2,344B 34.8B 236B 92.22B 1,152B 91.35B 89.39B 3,984B P/E 2026 *
20.5x
P/E 2027 * 19.3x
Enterprise Value 28.97B 25.44B 23.66B 21.71B 40.8B 2,790B 41.42B 281B 110B 1,371B 109B 106B 4,742B EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.83x
Free-Float
99.65%
Yield 2026 *
0.98%
Yield 2027 * 0.99%
1 day+1.98%
1 week+4.73%
Current month+5.99%
1 month+11.91%
3 months+12.50%
6 months+11.29%
Current year+18.29%
1 week 277.04
Extreme 277.035
298.58
1 month 262.1
Extreme 262.105
298.58
Current year 245
Extreme 245
298.58
1 year 244.52
Extreme 244.52
298.58
3 years 191.97
Extreme 191.97
298.58
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
02/07/26 Sell

EVP and President, Diagnostics

-234 0.0003%
02/07/26 Sell

General Counsel

-92 0.0001%
08/06/26 Sell

General Counsel

-762 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+1.98%+4.73%+10.86%+35.62% 24.34B
-1.02%-3.46%+85.72%+459.93% 37.52B
+2.02%-3.02%-25.07%-40.23% 7.33B
+0.97%-1.00%+9.97%+78.62% 4.84B
+4.27%+4.26%+13.76%+49.95% 3.05B
-6.75%-6.90%-27.44%+659.64% 1.75B
-2.46%-4.93%+116.36%-16.88% 1.81B
-2.07%-1.52%-14.82%-63.83% 1.78B
+5.58%-1.99%+14.91%+3.77% 1.74B
-5.15%-14.24%-2.43%-35.18% 1.41B
Average -0.26%-3.11%+18.18%+113.14% 8.56B
Weighted average by Cap. +0.29%-0.94%+41.43%+225.90%

Financials

2026 *2027 *
Net sales 14.71B 12.92B 12.02B 11.03B 20.72B 1,417B 21.04B 143B 55.75B 697B 55.23B 54.04B 2,408B 15.42B 13.54B 12.59B 11.56B 21.71B 1,485B 22.05B 150B 58.42B 730B 57.88B 56.63B 2,524B
Net income 1.18B 1.04B 968M 888M 1.67B 114B 1.69B 11.49B 4.49B 56.09B 4.45B 4.35B 194B 1.23B 1.08B 1B 922M 1.73B 118B 1.76B 11.93B 4.66B 58.24B 4.62B 4.52B 201B
Net Debt 4.63B 4.07B 3.78B 3.47B 6.52B 446B 6.63B 44.94B 17.56B 219B 17.39B 17.02B 758B 3.95B 3.47B 3.22B 2.96B 5.56B 380B 5.64B 38.27B 14.95B 187B 14.81B 14.49B 646B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
24/07/26 $296.77 +1.98% 916,285
23/07/26 $291.02 +3.40% 1,506,096
22/07/26 $281.46 +0.74% 854,980
21/07/26 $279.40 -0.74% 793,930
20/07/26 $281.48 -0.66% 777,645
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
296.77USD
Average target price
312.35USD
Spread / Average Target
+5.25%

Quarterly revenue - Rate of surprise